-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
BMS 488043
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/452296-83-22d.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 452296-83-2 |
| Description | BMS-488043 is a small-molecule HIV fusion inhibitor. |
Product Information
| Synonyms | BMS-488043;452296-83-2;BMS 043;BMS 488043;1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione;BMS043;BMS-043;CHEMBL238103;MKS21EJ435;1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridin-3-yl)-;1-Benzoyl-4-(2-(4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridin-3-yl)-2-oxoacetyl]piperazine;1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridin-3-yl)ethane-1,2-dione;UNII-MKS21EJ435;DBPMWRYLTBNCCE-UHFFFAOYSA-N;1-BENZOYL-4-(2-(4,7-DIMETHOXY-1H-PYRROLO(2,3-C)PYRIDIN-3-YL)-2-OXOACETYL)PIPERAZINE;BMS488043;SCHEMBL2688411;DTXSID501006367;GLXC-15766;BDBM50228465;AKOS040750864;DB05532;HY-14135;TS-08685;CS-0003220;NS00071850;Q27284087;n-(benzoyl)-n'-[(4,7-dimethoxy-6-azaindol-3-yl)-oxoacetyl]-piperazine;n-(benzoyl)-n'-[(4,7-dimethoxy-6-azaindol-3-yl)-oxoacetyl]piperazine;1-(4-benzoyl-1-piperazinyl)-2-(4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridin-3-yl)-1,2-ethanedione;1-[4-(benzoyl)piperazin-1-yl]-2-(4,7-dimethoxy-1h-pyrrolo[5,4-c]pyridin-3-yl)ethane-1,2-dione;857500-24-4;Piperazine, 1-benzoyl-4-[2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-1,2-dioxoethyl]-; |
| IUPAC Name | 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione |
| Molecular Weight | 405.4 |
| Molecular Formula | C22H15NO7 |
| Canonical SMILES | COC(=O)C(=O)/C(=C/C1=CC=C(O1)C2=CC=CC=C2[N+](=O)[O-])/C(=O)C3=CC=CC=C3 |
| InChI | InChI=1S/C22H22N4O5/c1-30-16-13-24-20(31-2)18-17(16)15(12-23-18)19(27)22(29)26-10-8-25(9-11-26)21(28)14-6-4-3-5-7-14/h3-7,12-13,23H,8-11H2,1-2H3 |
| InChIKey | DBPMWRYLTBNCCE-UHFFFAOYSA-N |
| Purity | ≥98% |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Application | HIV fusion inhibitor |
| Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
